Division of Gastroenterology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI.
Liver Transpl. 2013 Sep;19(9):991-1000. doi: 10.1002/lt.23688. Epub 2013 Aug 18.
Functional outcomes for long-term survivors of acute liver failure (ALF) are not well characterized. The aim of this prospective study was to determine health-related quality of life in long-term adult ALF survivors. Acute Liver Failure Study Group registry participants completed the Centers for Disease Control and Prevention Health-Related Quality of Life 14 and Short Form 36 (SF-36) questionnaires at 1- and/or 2-year follow-up study visits. Responses were compared among ALF subgroups and to those for available general US population controls. Among the 282 adult ALF patients, 125 had undergone liver transplantation (LT), whereas 157, including 95 acetaminophen overdose (APAP) patients and 62 non-APAP patients, were spontaneous survivors (SSs). APAP SS patients reported significantly lower general health scores and more days of impaired mental and physical health, activity limitations due to poor health, pain, depression, and anxiety in comparison with the other groups (P ≤ 0.001). There were no significant differences in coma grade or in the use of mechanical ventilation or intracranial pressure monitoring among the patient groups during their ALF hospitalization, but APAP SSs had significantly higher rates of psychiatric disease and substance abuse (P < 0.001). In comparison with the general US population, a greater proportion of the combined SS patients reported fair or poor health and ≥14 days of impaired physical/mental health and activity limitations due to poor health. In addition, a greater proportion of LT recipients reported ≥14 days of impaired physical/mental health. Similar results were observed with the SF-36 across the 3 ALF subgroups and in comparison with population controls. In conclusion, long-term adult survivors of ALF reported significantly lower quality of life scores than US population controls. Furthermore, APAP SS patients reported the lowest quality of life scores, possibly because of higher rates of premorbid psychiatric and substance abuse disorders.
长期存活的急性肝衰竭(ALF)患者的功能预后尚不清楚。本前瞻性研究旨在确定长期存活的成年 ALF 患者的健康相关生活质量。急性肝衰竭研究组登记参与者在 1 年和/或 2 年随访研究访问时完成了疾病控制和预防中心健康相关生活质量 14 项和 36 项简短形式(SF-36)问卷。将 ALF 亚组的反应与可获得的一般美国人群对照进行比较。在 282 名成年 ALF 患者中,125 例接受了肝移植(LT),而 157 例,包括 95 例对乙酰氨基酚过量(APAP)患者和 62 例非 APAP 患者,为自发性幸存者(SSs)。与其他组相比,APAP SS 患者报告的一般健康评分明显较低,并且在精神和身体健康受损、因健康状况不佳导致的活动受限、疼痛、抑郁和焦虑天数明显更多(P≤0.001)。在 ALF 住院期间,各组患者的昏迷程度或使用机械通气或颅内压监测无明显差异,但 APAP SS 患者的精神疾病和药物滥用发生率明显更高(P<0.001)。与一般美国人群相比,合并 SS 患者报告健康状况一般或较差以及≥14 天精神/身体健康受损和因健康状况不佳导致的活动受限的比例更高。此外,LT 受者报告的≥14 天精神/身体健康受损的比例更高。在 3 个 ALF 亚组和与人群对照的比较中,SF-36 也观察到了相似的结果。总之,长期存活的 ALF 成年幸存者报告的生活质量评分明显低于美国人群对照。此外,APAP SS 患者报告的生活质量评分最低,可能是因为前期精神和药物滥用障碍的发生率较高。